On November 21, 2022, the FDA’s Center for Food Safety and Applied Nutrition issued warning letters to five manufacturers of food and beverages containing cannabidiol (CBD).
These letters mark the latest in a continued trend of FDA enforcement against CBD in recent years that dicentra has covered. The letters outline 2 major compliance violations:
You can access the warning letters here.
If you are a manufacturer of a full-spectrum hemp extract for use in foods or dietary ingredients, and you are concerned that your product may be adulterated, contact us today.
dicentra can help you obtain GRAS status, ensure that your dietary supplement and food labelling is compliant with all applicable FDA rules, regulations, and guidance documents, and can assist your business through the process of clinical trial design and trial execution.